Immune Gene Networks from Lung Cancer Patients Treated with Immune Checkpoint Inhibitors
Open Access
- 12 March 2024
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 12 (3) , 628
Abstract
The association between immune checkpoint inhibitors (ICIs) and immune gene networks in squamous lung cancer (LUSC) and lung adenocarcinoma (LUAD) was studied. Immune gene networks were constructed using RNA-seq data from the gene expression omnibus (GEO) database. Datasets with more than 10 samples of normal control and tumor tissues were selected; of these, GSE87340, GSE120622, and GSE111907 were suitable for analysis. Gene set enrichment for pathway analysis was performed. For immune gene network construction, 998 unique immune genes were selected from 21 pathways in the Kyoto Encyclopedia of Genes and Genomes (KEGG). Gene function annotation was performed based on the KEGG, Gene Ontology, and Reactome databases. Tumor tissues showed decreased coagulation, hematopoiesis, and innate immune pathways, whereas complement- and coagulation-related genes were prominent in the tumor immune gene network. The average numbers of neighbors, clustering coefficients, network diameters, path lengths, densities, and heterogeneities were highest for normal tissue, followed by LUAD and LUSC. Decreased coagulation genes, which were prominent in tumor immune networks, imply functional attenuation. LUAD was deviated from normal tissue, based on network parameters. Tumor tissues showed decreased immune function, and the deviation of LUSC from normal tissue might explain LUSC’s better therapeutic response to ICI treatment.Keywords
Funding Information
- Catholic Medical Center Research Foundation
This publication has 39 references indexed in Scilit:
- Immune checkpoint inhibitors alone vs immune checkpoint inhibitors—combined chemotherapy for NSCLC patients with high PD-L1 expression: a network meta-analysisBritish Journal of Cancer, 2022
- Quantifying the efficacy of checkpoint inhibitors on CD8+ cytotoxic T cells for immunotherapeutic applications via single-cell interactionCell Death & Disease, 2020
- Fucosyltransferase 4 shapes oncogenic glycoproteome to drive metastasis of lung adenocarcinomaEBioMedicine, 2020
- Four-year survival with nivolumab in patients with previously treated advanced non-small-cell lung cancer: a pooled analysisThe Lancet Oncology, 2019
- Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotypeNature Biotechnology, 2019
- IKZF1 Enhances Immune Infiltrate Recruitment in Solid Tumors and Susceptibility to ImmunotherapyCell Systems, 2018
- A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 ProfilesCell, 2017
- Transcript-level expression analysis of RNA-seq experiments with HISAT, StringTie and BallgownNature Protocols, 2016
- Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomasNature Genetics, 2016
- Network medicine: a network-based approach to human diseaseNature Reviews Genetics, 2010